Clinical Trial NCT04702568
Trial
BioCryst – BCX9930-201 (NCT04702568)
Clinical trial ID
NCT04702568
Drug name
BCX9930
Company:
BioCryst
Drug trade name
---
Clinicaltrials.gov
Learn more
Phase of study
2
Current status
Active, not recruiting
Start
12/2020
Substance
Low molecular compound
Research question
Long-term evaluation
Delivery method of drug
Oral
Frequency
2 x daily
Clinical trial locations
Austria South Africa UK